在原住民祖先的秘鲁人口中对抗结核病药物的药物遗传学研究
Luis Jaramillo-Valverde1,2, Mary K Horton3, Julio A Poterico1,4
1INBIOMEDIC, Research and Technological Center, Lima, Peru.
Pharmacology research & perspectives
|June 15, 2025
概括
秘鲁人口中的遗传变异会影响结核病药物反应. 亚马逊人群的肝损伤风险较高,而安第斯人群的风险较低,为个性化结核病治疗提供了信息.
科学领域:
- 药物基因组学 药物基因组学
- 结核病的治疗方法
- 遗传流行病学遗传流行病学
背景情况:
- 结核病 (TB) 治疗可能导致药物不良反应,特别是药物诱导性肝损伤 (DILI).
- 关于拉丁美洲和秘鲁本土人口中DILI遗传风险因素的数据有限.
- 了解遗传变异对于个性化结核病治疗至关重要.
研究的目的:
- 确定结核病药物代谢基因型在秘鲁本土亚种群中的患病率.
- 确定与秘鲁药物诱导性肝损伤 (DILI) 风险相关的遗传因素.
- 将秘鲁的基因型频率与全球数据集进行比较.
主要方法:
- 来自秘鲁基因组项目 (PGP) 254 名参与者的遗传数据的横截面分析.
- 对23个参与代谢结核病药物 (伊索尼亚齐德,里法,乙胺醇,皮拉津胺胺) 的基因进行分析.
- 在秘鲁三个亚种群的基因型频率的比较:海岸,安第斯和亚马逊.
主要成果:
- 在AGBL4,NAT2,GSTP1,SLCO1B1,NOS和CYP2B6的亚种群中发现了基因型频率的显著差异.
- 由于AGBL4,GSTP1和SLCO1B1.1.中普遍存在的肝毒性等位基因,亚马逊人群的DILI风险更高.
- 安第斯人群显示,与NOS基因等位基因相关的肝毒性风险较低.
结论:
- 与全球人口相比,秘鲁本土人口表现出明显的结核病药物代谢基因型模式.
- 鉴定的遗传变异可以为秘鲁的结核病治疗提供个性化的治疗策略.
- 研究结果突出了对特定人群的药物基因组数据的需求,以优化结核病管理.
相关概念视频
Pulmonary Tuberculosis V
249
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
249
Pulmonary Tuberculosis IV
212
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
212
Pulmonary Tuberculosis I
335
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
335
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K
Analysis of Population Pharmacokinetic Data
397
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
397
Pulmonary Tuberculosis II
389
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
389


